Manufacturer record
VTV Formulations India Pvt Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by VTV Formulations India Pvt Ltd (Uttarakhand) was declared Not of Standard Quality in June 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: GTV26001, Cilnidipine Tablets IP 10 mg, (exp Dec 2027). RDTL, Ernakulam (state lab) found it not of standard quality: Sample does not conform to IP 2022 standards. This particular batch sample fails the test Dissolution. Listed in the June 2026 alert.
Records by type
1 record linked to VTV Formulations India Pvt Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Cilnidipine Tablets IP 10 mg, | Batch GTV26001Mfg Jan 2026 · Exp Dec 2027 | Sample does not conform to IP 2022 standards. This particular batch sample fails the test DissolutionDissolution | RDTL, ErnakulamState lab | Jun 2026 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.